Literature DB >> 19815814

Rare autosomal dominant POLG1 mutation in a family with metabolic strokes, posterior column spinal degeneration, and multi-endocrine disease.

Sarah E Hopkins1, Arthur Somoza, Donald L Gilbert.   

Abstract

DNA POLG is the only mitochondrial DNA polymerase and is encoded by nuclear DNA. Depending on the location and inheritance, mutations in POLG1, the catalytic subunit, can cause symptoms including severe infantile epilepsy, metabolic strokes, chronic ataxia, neuropathy, and ophthalmoplegia. We reviewed medical records and conducted extensive interviews with the family of identical twin probands with a mutation in the linker region of DNA polymerase gamma 1 (POLG1) (G517V) and discuss postmortem findings from their grandmother. Both twins developed type I diabetes, adrenal insufficiency, hypothyroidism, and psychiatric problems in addition to neurological difficulties including bilateral basal ganglia infarcts, headaches, and seizures. The maternal grandmother, now deceased, had psychosis and balance problems, and postmortem findings include lacunar infarcts in the basal ganglia (caudate nucleus, putamen, and globus pallidus) and posterior spinal column degeneration. We discuss novel aspects of their presentation and implications for practice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19815814     DOI: 10.1177/0883073809343313

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  15 in total

1.  Stroke and Stroke-Like Symptoms in Patients with Mutations in the POLG1 Gene.

Authors:  Waleed Brinjikji; Jerry W Swanson; Carrie Zabel; Peter J Dyck; Jennifer A Tracy; Ralitza H Gavrilova
Journal:  JIMD Rep       Date:  2011-06-22

2.  Novel POLG mutations and variable clinical phenotypes in 13 Italian patients.

Authors:  Paola Da Pozzo; Elena Cardaioli; Anna Rubegni; Gian Nicola Gallus; Alessandro Malandrini; Alessandra Rufa; Carla Battisti; Maria Alessandra Carluccio; Raffaele Rocchi; Fabio Giannini; Amedeo Bianchi; Michelangelo Mancuso; Gabriele Siciliano; Maria Teresa Dotti; Antonio Federico
Journal:  Neurol Sci       Date:  2017-01-27       Impact factor: 3.307

3.  Isolated cortical vein thrombosis in autoimmune polyglandular syndrome type 2.

Authors:  Paloma Gonzalez-Perez; Marcelo Correia; Aristides A Capizzano; Harold P Adams
Journal:  Neurology       Date:  2016-03-02       Impact factor: 9.910

4.  Acute mental status change as the presenting feature of adrenal insufficiency in a patient with autoimmune polyglandular syndrome type II and stroke.

Authors:  Sara Watson; Shekar Raj; Erica Eugster; Juan Sanchez
Journal:  J Pediatr Endocrinol Metab       Date:  2014-05       Impact factor: 1.634

5.  Biochemical analysis of the G517V POLG variant reveals wild-type like activity.

Authors:  Rajesh Kasiviswanathan; William C Copeland
Journal:  Mitochondrion       Date:  2011-08-11       Impact factor: 4.160

Review 6.  Mitochondrial disease and endocrine dysfunction.

Authors:  Jasmine Chow; Joyeeta Rahman; John C Achermann; Mehul T Dattani; Shamima Rahman
Journal:  Nat Rev Endocrinol       Date:  2016-10-07       Impact factor: 43.330

7.  POLG1 p.R722H mutation associated with multiple mtDNA deletions and a neurological phenotype.

Authors:  Tuomas Komulainen; Reetta Hinttala; Mikko Kärppä; Leila Pajunen; Saara Finnilä; Hannu Tuominen; Heikki Rantala; Ilmo Hassinen; Kari Majamaa; Johanna Uusimaa
Journal:  BMC Neurol       Date:  2010-05-03       Impact factor: 2.474

Review 8.  Overview of Atypical Diabetes.

Authors:  Jaclyn Tamaroff; Marissa Kilberg; Sara E Pinney; Shana McCormack
Journal:  Endocrinol Metab Clin North Am       Date:  2020-10-14       Impact factor: 4.741

9.  Quantitative multiplex PCR of short fluorescent fragments for the detection of large intragenic POLG rearrangements in a large French cohort.

Authors:  Cécile Rouzier; Annabelle Chaussenot; Valérie Serre; Konstantina Fragaki; Sylvie Bannwarth; Samira Ait-El-Mkadem; Shahram Attarian; Elsa Kaphan; Aline Cano; Emilien Delmont; Sabrina Sacconi; Bénédicte Mousson de Camaret; Marlène Rio; Anne-Sophie Lebre; Claude Jardel; Romain Deschamps; Christian Richelme; Jean Pouget; Brigitte Chabrol; Véronique Paquis-Flucklinger
Journal:  Eur J Hum Genet       Date:  2013-08-07       Impact factor: 4.246

10.  Sensory neuronopathy in patients harbouring recessive polymerase γ mutations.

Authors:  Nichola Z Lax; Roger G Whittaker; Philippa D Hepplewhite; Amy K Reeve; Emma L Blakely; Evelyn Jaros; Paul G Ince; Robert W Taylor; Peter R W Fawcett; Doug M Turnbull
Journal:  Brain       Date:  2011-12-20       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.